Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia

Int J Cardiol. 2015 Apr 1:184:570-572. doi: 10.1016/j.ijcard.2015.03.063. Epub 2015 Mar 4.

Authors

Valéria A Machado¹, Francisco A Fonseca¹, Henrique A Fonseca¹, Daniela T Malina¹, Waleria T Fonzar¹, Sílvio A Barbosa¹, José M Santana², Maria C Izar³

Affiliations

¹ Department of Medicine, Cardiology Division, Federal University of Sao Paulo, Sao Paulo, SP, Brazil.
² TASQA Analytical Services Ltd., Campinas, SP, Brazil.
³ Department of Medicine, Cardiology Division, Federal University of Sao Paulo, Sao Paulo, SP, Brazil. Electronic address: mcoizar@terra.com.br.

PMID: 25767019
DOI: 10.1016/j.ijcard.2015.03.063

No abstract available

Keywords: Ezetimibe; Familial hypercholesterolemia; LDL-cholesterol; Phytosterols; Statins; Sterols.

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Anticholesteremic Agents / administration & dosage
Anticholesteremic Agents / adverse effects
Drug Monitoring
Ezetimibe, Simvastatin Drug Combination* / administration & dosage
Ezetimibe, Simvastatin Drug Combination* / adverse effects
Female
Humans
Hyperlipoproteinemia Type II / blood
Hyperlipoproteinemia Type II / drug therapy*
Lipid Metabolism / drug effects*
Male
Middle Aged
Phytosterols* / administration & dosage
Phytosterols* / adverse effects
Simvastatin* / administration & dosage
Simvastatin* / adverse effects
Treatment Outcome

Substances

Anticholesteremic Agents
Ezetimibe, Simvastatin Drug Combination
Phytosterols
Simvastatin